Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Starling Oncology Inc. May 7, 202598.4%
-
Starling Oncology Inc. June 13, 202499.6%
-
AdaptHealth Corp. June 21, 202359.1%
-
Starling Oncology Inc. June 15, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2025 | Starling Oncology Inc. | Other | −287,756 | — | — |
| Jun 18, 2025 | Starling Oncology Inc. | Derivative conversion | +620,400 | — | — |
| Jun 17, 2025 | Starling Oncology Inc. | In-the-money exercise | +679,224 | $1.20 | $815,069 |
| Jun 17, 2025 | Starling Oncology Inc. | Derivative conversion | +159,500 | — | — |
| Jun 17, 2025 | Starling Oncology Inc. | Shares withheld for tax | −311,128 | $2.62 | $815,155 |
| Mar 26, 2025 | Starling Oncology Inc. | Open-market purchase | +1,358,448 | $1.04 | $1,412,786 |
| Nov 22, 2024 | Starling Oncology Inc. | Grant or award | +80,000 | — | — |
| Jun 18, 2024 | AdaptHealth Corp. | Shares withheld for tax | −3,559 | $9.89 | $35,199 |
| May 7, 2024 | AdaptHealth Corp. | Shares withheld for tax | −8,547 | $9.85 | $84,188 |
| Apr 30, 2024 | AdaptHealth Corp. | Grant or award | +8,829 | — | — |
| Mar 2, 2024 | AdaptHealth Corp. | Grant or award | +21,206 | — | — |
| Feb 29, 2024 | AdaptHealth Corp. | Shares withheld for tax | −8,984 | $10.23 | $91,906 |
| Jan 2, 2024 | AdaptHealth Corp. | Shares withheld for tax | −9,226 | $7.26 | $66,981 |
| Dec 29, 2023 | AdaptHealth Corp. | Grant or award | +22,291 | — | — |
| Dec 26, 2023 | Starling Oncology Inc. | Grant or award | +80,000 | — | — |
Questions about Richard A. Barasch
What boards is Richard A. Barasch on?
Richard A. Barasch sits on the boards of AdaptHealth Corp. and Starling Oncology Inc.
Has Richard A. Barasch been a CEO?
Yes — Richard A. Barasch was CEO of AdaptHealth Corp. (Until May 2024).
How long has Richard A. Barasch served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.